The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer
Publication
, Journal Article
Armstrong, AJ; Halabi, S; Tannock, IF; Ronald, D; Eisenberger, MA
Published in: Journal of Clinical Oncology
May 20, 2008
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2008
Volume
26
Issue
15_suppl
Start / End Page
5074 / 5074
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Halabi, S., Tannock, I. F., Ronald, D., & Eisenberger, M. A. (2008). The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer. Journal of Clinical Oncology, 26(15_suppl), 5074–5074. https://doi.org/10.1200/jco.2008.26.15_suppl.5074
Armstrong, A. J., S. Halabi, I. F. Tannock, D. Ronald, and M. A. Eisenberger. “The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 5074–5074. https://doi.org/10.1200/jco.2008.26.15_suppl.5074.
Armstrong AJ, Halabi S, Tannock IF, Ronald D, Eisenberger MA. The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer. Journal of Clinical Oncology. 2008 May 20;26(15_suppl):5074–5074.
Armstrong, A. J., et al. “The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2008, pp. 5074–5074. Crossref, doi:10.1200/jco.2008.26.15_suppl.5074.
Armstrong AJ, Halabi S, Tannock IF, Ronald D, Eisenberger MA. The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008 May 20;26(15_suppl):5074–5074.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2008
Volume
26
Issue
15_suppl
Start / End Page
5074 / 5074
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences